Navigation Links
WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years
Date:6/28/2012

SHANGHAI, June 28, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, announced that it has been selected as one of the Top Ten Outsourcing Enterprise in China for 2012 by China's Ministry of Commerce (MOC). The list was announced at China's Fifth Annual International Service Outsourcing Cooperation Conference, held in Nanjing on June 20, 2012. WuXi PharmaTech is the only life science R&D service company among the top ten outsourcing enterprises.

Because of its creative business model of serving life science R&D industry and contribution to China's life science industry, WuXi PharmaTech has been selected into the Top 10 list for five consecutive years since the selection was initiated in 2008 by MOC. Earlier in 2011, Dr. Ge Li, Chairman and CEO, was named a Top Ten Contributor to China's Outsourcing Industry.

"We are honored to be consistently recognized as a top outsourcing company in China," Dr. Li said. "This speaks volume for WuXi's service business model. As a leading life science R&D service company, we will strive to improve our capabilities and capacities to better serve our pharmaceutical, biotechnology and medical device customers and partners, to help bring new products into market sooner and more cost effectively to benefit patients in needs."

Issued annually by Council for International Investment Promotion (CCIIP), a non-profit organization under Ministry of Commerce, the Top Ten Outsourcing Chinese Enterprise List recognizes the best outsourcing enterprises in China that have achieved great business growth on a yearly basis.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit http://www.wuxiapptec.com or contact:

Aaron Shi (for the media)
Tel:   +86-21-5046-4362
Email: Aaron_Shi@wuxiapptec.com

Ronald Aldridge (for investors)
Tel:   +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Announces Third-Quarter 2011 Results
2. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
3. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
4. Sequenom Named to NASDAQ Global Select Market
5. U of Toronto experiment named top breakthrough of 2011 by Physics World
6. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
7. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
8. Royals Batter Billy Butler Named Hutch Award Winner
9. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
10. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
11. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... , ... July 17, 2017 ... ... technology-enabled clinical trial solutions, today announced safety software company AB Cube has ... eHealth Solutions business segment to advance technology innovation across life sciences and ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... Hsing, Ph.D. , recently participated in the BiG (Biomedical Innovation Group) annual meeting ... by discussions of CAR-T (chimeric antigen receptor T-cell) therapy, a rapidly developing highly ...
(Date:7/16/2017)... N.J. (PRWEB) , ... July 16, 2017 , ... ... laboratory equipment and analytical instruments announced the launch of its new line of ... introduced five rocking and waving shaker models (both analog and digital) for laboratory ...
(Date:7/14/2017)... ... July 14, 2017 , ... ... company . Sonic Manufacturing Technologies has installed a solar system on its roof ... three-year period,” the President of Sonic, Kenneth Raab stated. The company’s proud history ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):